SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-019877
Filing Date
2023-02-13
Accepted
2023-02-13 17:16:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm236504d2_sc13g.htm SC 13G 37366
  Complete submission text file 0001104659-23-019877.txt   38612
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Subject) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93555 | Film No.: 23619960
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address
Shemesh Shay (Filed by) CIK: 0001896056 (see all company filings)

Type: SC 13G